Study to Determine the Effect of BMS-791325 on the ECG QTcF Interval in Healthy Subjects
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether BMS-791325 has an effect on the
electrocardiogram (ECG) interval QT corrected for Fridericia's method (QTcF).
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination